Progressing personalised cell therapies in oncology
This article discusses the current landscape of CAR T therapies and highlights the potential of a novel BCMA-targeted oncology treatment.
Source: europeanpharmaceuticalreview.com
Stay updated with breaking news from Engineering Immune Cells. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
This article discusses the current landscape of CAR T therapies and highlights the potential of a novel BCMA-targeted oncology treatment.
Wider availability of cheaper CAR-T cell therapy or engineering immune cells to treat blood cancer and a government HPV vaccination programme will be among the key breakthroughs